HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors

This study aims to construct a structuralized follow-up model for survivors of childhood hematological malignancies in China. Using a multicenter prospective cohort design, it will identify the burden and risk factors of late effects. The study hypothesizes that a standardized follow-up path managed by an electronic platform will improve follow-up compliance and reduce the missed diagnosis rate of late effects.

NCT Number	NCT07483749
Lead Sponsor	The Children's Hospital of Zhejiang University School of Medicine Collaborators: Ningbo Women & Children's Hospital, Hangzhou Children's Hospital
Conditions	Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Lymphoma, Leukemia, Pediatric
Enrollment	400 participants
Start Date	2026-03-25
Primary Completion	2028-12 (estimated)
Study Completion	2028-12 (estimated)
Updated on ClinicalTrials.gov	2026-03-19